HRP20000741B1 - Water soluble azoles as broad-spectrum antifungals - Google Patents

Water soluble azoles as broad-spectrum antifungals

Info

Publication number
HRP20000741B1
HRP20000741B1 HR20000741A HRP20000741A HRP20000741B1 HR P20000741 B1 HRP20000741 B1 HR P20000741B1 HR 20000741 A HR20000741 A HR 20000741A HR P20000741 A HRP20000741 A HR P20000741A HR P20000741 B1 HRP20000741 B1 HR P20000741B1
Authority
HR
Croatia
Prior art keywords
alkyl
amino
aryl
mono
alkyloxy
Prior art date
Application number
HR20000741A
Other languages
English (en)
Croatian (hr)
Inventor
Meerpoel Lieven
Jacobus Leo
Jozef Elisabeth Van Der Veken Louis
Christopher Odds Frank
Heeres Jan
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of HRP20000741A2 publication Critical patent/HRP20000741A2/hr
Publication of HRP20000741B1 publication Critical patent/HRP20000741B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HR20000741A 1998-05-14 2000-11-02 Water soluble azoles as broad-spectrum antifungals HRP20000741B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98201588A EP0957101A1 (en) 1998-05-14 1998-05-14 Water soluble azoles as broad-spectrum antifungals
PCT/EP1999/003243 WO1999058530A1 (en) 1998-05-14 1999-05-06 Water soluble azoles as broad-spectrum antifungals

Publications (2)

Publication Number Publication Date
HRP20000741A2 HRP20000741A2 (en) 2001-06-30
HRP20000741B1 true HRP20000741B1 (en) 2009-02-28

Family

ID=8233724

Family Applications (2)

Application Number Title Priority Date Filing Date
HR20000740A HRP20000740B1 (en) 1998-05-14 2000-11-02 Water soluble azoles as broad-spectrum antifungals
HR20000741A HRP20000741B1 (en) 1998-05-14 2000-11-02 Water soluble azoles as broad-spectrum antifungals

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HR20000740A HRP20000740B1 (en) 1998-05-14 2000-11-02 Water soluble azoles as broad-spectrum antifungals

Country Status (32)

Country Link
US (2) US6384030B1 (zh)
EP (3) EP0957101A1 (zh)
JP (2) JP2002514646A (zh)
KR (2) KR100593395B1 (zh)
CN (2) CN1135229C (zh)
AR (2) AR016480A1 (zh)
AT (2) ATE238296T1 (zh)
AU (2) AU751135B2 (zh)
BG (2) BG64388B1 (zh)
BR (2) BR9910448A (zh)
CA (2) CA2331187C (zh)
CO (1) CO5021227A1 (zh)
CZ (2) CZ299481B6 (zh)
DE (2) DE69902461T2 (zh)
DK (1) DK1077976T3 (zh)
EE (2) EE04346B1 (zh)
ES (2) ES2182531T3 (zh)
HK (2) HK1033312A1 (zh)
HR (2) HRP20000740B1 (zh)
HU (2) HUP0103536A3 (zh)
IL (2) IL139647A0 (zh)
MY (2) MY122147A (zh)
NO (2) NO319851B1 (zh)
NZ (2) NZ507965A (zh)
PL (2) PL194086B1 (zh)
PT (1) PT1077976E (zh)
SI (1) SI1077976T1 (zh)
SK (2) SK286156B6 (zh)
TR (2) TR200003323T2 (zh)
TW (2) TWI259835B (zh)
WO (2) WO1999058529A1 (zh)
ZA (2) ZA200007173B (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals
NZ521241A (en) * 2000-03-07 2004-02-27 Ranbaxy Lab Ltd Azole compounds as therapeutic agents for fungal infections
EP1413301A1 (fr) * 2002-10-24 2004-04-28 Bayer CropScience SA Médicaments antifongiques à base de dérivés d'arylamidine
ITMI20032020A1 (it) * 2003-10-17 2005-04-18 Italfarmaco Spa Nuovi agenti antifungini azolici con diminuita interazione con i citocromi metabolici
AR052342A1 (es) * 2004-12-21 2007-03-14 Janssen Pharmaceutica Nv Derivados sustituidos de triazolona,tetrazolona e imidazolona con actividad selectiva antagonista de alfa2c-adenoreceptores
AU2011254654B2 (en) * 2010-05-19 2016-01-07 Sandoz Ag Process for the preparation of chiral triazolones
US9346791B2 (en) 2011-09-07 2016-05-24 The Johns Hopkins University Itraconazole analogs and use thereof
US11028078B2 (en) 2011-09-07 2021-06-08 The Johns Hopkins University Itraconazole analogs and use thereof
JP6414831B2 (ja) 2013-06-07 2018-10-31 ザ カリフォルニア インスティテュート フォー バイオメディカル リサーチ 繊維症の小分子阻害剤
CN107001343B (zh) 2014-12-05 2020-12-11 普尔莫赛德有限公司 抗真菌的化合物
CN107404878B (zh) * 2014-12-10 2021-03-30 斯克利普斯研究所 纤维化的小分子抑制剂
SG11201708007VA (en) 2015-05-21 2017-12-28 Pulmocide Ltd Antifungal 4-(4-(4-(((3r,5r)-5-((1 h -1,2,4-triazol-1 -yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)- 3-methylphenyl)piperazin-1 -yl )-n -(2-h yd roxycyc lo h exyl) b e nzam i d e, or a pharmaceutically acceptable salt thereof.
CN105237392B (zh) * 2015-11-24 2017-12-12 辽宁渤大化工有限公司 芳烷基水杨酸及其衍生物的制备方法
WO2019040363A1 (en) * 2017-08-20 2019-02-28 University Of Connecticut AZOLE-TYPE COMPOUND ANALOGUES AND METHODS OF USE
CN111138421A (zh) * 2019-12-26 2020-05-12 上海英诺富成生物科技有限公司 抗真菌水溶性化合物及其制备方法与应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017407A1 (en) * 1993-12-21 1995-06-29 Schering Corporation Tetrahydrofuran antifungals
WO1995019983A1 (en) * 1994-01-24 1995-07-27 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
WO1996038443A1 (en) * 1995-06-02 1996-12-05 Schering Corporation Tetrahydrofuran antifungals
WO1997000255A1 (en) * 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals
WO1998034934A1 (en) * 1997-02-11 1998-08-13 Janssen Pharmaceutica N.V. Amino acid ester containing azole antifungals

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4267179A (en) * 1978-06-23 1981-05-12 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-phenylpiperazin-1-yl-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
EP0631578B1 (en) * 1992-03-18 2001-05-23 Janssen Pharmaceutica N.V. Itraconazole and saperconazole stereoisomers
FI98688C (fi) * 1994-07-20 1997-07-25 Nokia Telecommunications Oy Menetelmä lyhytsanomalähetyksen käynnistämiseksi solukkoradiojärjestelmässä, solukkoradiojärjestelmä sekä solukkoradiojärjestelmän tilaajarekisteri
EP0957101A1 (en) * 1998-05-14 1999-11-17 Janssen Pharmaceutica N.V. Water soluble azoles as broad-spectrum antifungals

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995017407A1 (en) * 1993-12-21 1995-06-29 Schering Corporation Tetrahydrofuran antifungals
WO1995019983A1 (en) * 1994-01-24 1995-07-27 Janssen Pharmaceutica N.V. Watersoluble azole antifungals
WO1996038443A1 (en) * 1995-06-02 1996-12-05 Schering Corporation Tetrahydrofuran antifungals
WO1997000255A1 (en) * 1995-06-19 1997-01-03 Schering Corporation Tetrahydrofuran antifungals
WO1998034934A1 (en) * 1997-02-11 1998-08-13 Janssen Pharmaceutica N.V. Amino acid ester containing azole antifungals

Also Published As

Publication number Publication date
CA2331141A1 (en) 1999-11-18
EE04346B1 (et) 2004-08-16
ES2198915T3 (es) 2004-02-01
TWI259835B (en) 2006-08-11
IL139649A0 (en) 2002-02-10
BG104717A (en) 2001-07-31
ZA200007459B (en) 2002-09-13
HRP20000740B1 (en) 2003-12-31
CN1300287A (zh) 2001-06-20
TW572899B (en) 2004-01-21
WO1999058529A1 (en) 1999-11-18
BR9910448A (pt) 2001-01-02
EP1077975A1 (en) 2001-02-28
ATE221884T1 (de) 2002-08-15
MY122147A (en) 2006-03-31
PT1077976E (pt) 2002-12-31
NZ507965A (en) 2002-05-31
TR200003323T2 (tr) 2001-02-21
US6384030B1 (en) 2002-05-07
BR9911057A (pt) 2001-02-06
ATE238296T1 (de) 2003-05-15
CA2331141C (en) 2008-10-28
CZ299481B6 (cs) 2008-08-13
PL344037A1 (en) 2001-09-24
SI1077976T1 (en) 2003-02-28
HRP20000740A2 (en) 2001-10-31
PL194085B1 (pl) 2007-04-30
IL139647A0 (en) 2002-02-10
JP2002514646A (ja) 2002-05-21
AU4361599A (en) 1999-11-29
HK1033312A1 (en) 2001-08-24
CZ298702B6 (cs) 2007-12-27
CZ20004108A3 (en) 2001-05-16
HUP0103536A2 (hu) 2002-07-29
DE69902461T2 (de) 2003-04-10
SK16822000A3 (sk) 2001-07-10
SK285763B6 (sk) 2007-07-06
EE200000651A (et) 2002-04-15
DK1077976T3 (da) 2002-12-02
KR100593395B1 (ko) 2006-06-28
AU758876B2 (en) 2003-04-03
BG104933A (en) 2001-10-31
NZ507966A (en) 2002-10-25
EP1077976B1 (en) 2002-08-07
CA2331187A1 (en) 1999-11-18
NO20005712L (no) 2000-12-07
CN1300288A (zh) 2001-06-20
EP0957101A1 (en) 1999-11-17
AU4141799A (en) 1999-11-29
DE69907171T2 (de) 2004-02-05
HK1032781A1 (en) 2001-08-03
KR20010041480A (ko) 2001-05-25
AR016480A1 (es) 2001-07-04
MY120248A (en) 2005-09-30
AR016482A1 (es) 2001-07-04
PL344047A1 (en) 2001-09-24
BG64954B1 (bg) 2006-10-31
DE69902461D1 (de) 2002-09-12
HUP0102031A2 (hu) 2002-05-29
BG64388B1 (bg) 2004-12-30
NO319760B1 (no) 2005-09-12
KR100575147B1 (ko) 2006-05-03
EP1077976A1 (en) 2001-02-28
JP2002514645A (ja) 2002-05-21
CN1135229C (zh) 2004-01-21
KR20010042852A (ko) 2001-05-25
EP1077975B1 (en) 2003-04-23
PL194086B1 (pl) 2007-04-30
NO20005713D0 (no) 2000-11-13
TR200003322T2 (tr) 2001-02-21
NO319851B1 (no) 2005-09-19
IL139649A (en) 2004-09-27
SK286156B6 (sk) 2008-04-07
ZA200007173B (en) 2002-03-04
EE04311B1 (et) 2004-06-15
CO5021227A1 (es) 2001-03-27
ES2182531T3 (es) 2003-03-01
CA2331187C (en) 2008-11-18
NO20005713L (no) 2001-01-11
HUP0103536A3 (en) 2002-08-28
EE200000657A (et) 2002-04-15
SK16812000A3 (sk) 2001-08-06
US6448244B1 (en) 2002-09-10
AU751135B2 (en) 2002-08-08
NO20005712D0 (no) 2000-11-13
WO1999058530A1 (en) 1999-11-18
HUP0102031A3 (en) 2002-10-28
DE69907171D1 (de) 2003-05-28
CZ20004109A3 (en) 2001-05-16
CN1137118C (zh) 2004-02-04
HRP20000741A2 (en) 2001-06-30

Similar Documents

Publication Publication Date Title
HRP20000741B1 (en) Water soluble azoles as broad-spectrum antifungals
ES2126573T3 (es) Derivado de pirazol (1,5-a)pirimidina y agente antiinflamatorio que contiene este derivado.
ES2400104T3 (es) Proceso para preparación de 5-fluoro-1H-pirazolo[3,4-b]piridin-3-amina y derivados de la misma
CA2339630A1 (en) Carboline derivatives as cgmp phosphodiesterase inhibitors
YU47101B (sh) Supstituisani piroli i postupak za njihovu proizvodnju
HRP20090151T3 (en) Indozolone derivatives as 11b-hsd1 inhibitors
RS51189B (sr) Supstituisani derivati propenil piperazina kao novi inhibitori histonske deacetilaze
TR199900481T2 (xx) �ndazol t�revleri; fosfodiesteraz tip IV inhibit�rleri olarak kullan�mlar�.
CO5180553A1 (es) Derivados de pirimidona de la formula (1) o sales de los mismos y medicamentos que contienen dichos derivados como ingrediente activo
MY153393A (en) Amino nicotinic and isonicotinic acid derivatives as dhodh as inhibitors
MY129540A (en) Quinazoline derivatives, pharmaceutical compositions containing them processes for their preparation and their use in the production of an antiangiogenic and/or vascular permeability reducing effect
MY107756A (en) Piperazine derivatives.
BRPI9913097B8 (pt) derivado heterocíclico de carboxamida contendo nitrogênio ou um sal do mesmo
MXPA05007671A (es) Derivados de triazina como absorbedores de uv.
CA2267322A1 (en) Pde iv inhibiting 2-cyanoiminoimidazole derivatives
NZ503822A (en) 2-halo-6-O-substituted erythromycin derivatives, a process for their preparation and pharmaceuticals thereof, useful for treating bacterial infections
RS54382B1 (en) ANTI-BACTERIAL DERIVATIVES OF HINOLINE
MXPA04000065A (es) Derivados de aril(o ehteroaril)azolilcarbinoles para el tratamiento de la incontinencia urinaria.
BR0004709A (pt) Derivados de quinolin-4-ila ii
BG104718A (en) Pde iv inhibiting pyridine derivatives
CA2292775A1 (en) Cyanoguanidines as cell proliferation inhibitors
TR199902019T2 (xx) �kame edilmi� tiazolidion' un haz�rlanmas� i�in proses.
MY117936A (en) 1,3-dihydro-2h-imidazol-2-one derivatives
DE3569528D1 (en) Penem derivatives, methods of producing them, their use and pharmaceutical compositions
MX9709465A (es) Derivados de bencimidazol 2-sustituidos como inhibidores de la proliferacion de celulas del musculo liso.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20080505

Year of fee payment: 10

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20090507